m_PAC AG Competitors

Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Cimpress is a strategically-focused group of more than a dozen businesses, each operating in a largely autonomous manner other than as it relates to the select few shared strategic and corporate activities that we maintain centrally. Cimpress businesses include Drukwerkdeal, Exaprint, National Pen, Pixartprinting, Printi, Vistaprint and WIRmachenDRUCK. Founded by Robert Keane, who remains President & CEO today, the company has been passionate about empowering people to make an impression through individually meaningful, personalized physical products for more than 20 years. To learn more, visit http://www.cimpress.com.

We are Syntegon, a leading global technology company and strategic partner to the pharmaceutical, biotech, and food industries. With a strategic focus on the growing pharmaceutical and biotech sectors, we play a vital role in global healthcare, providing in-depth process expertise and mission-critical technologies for the safe, efficient, and compliant production of essential medicines. In the food sector, we are recognized for our high-speed, high-precision packaging solutions, drawing on unique engineering excellence to help food manufacturers improve performance and product quality. On LinkedIn, our goal is to create a space for pharmaceutical, biotech and food professionals to connect, discuss industry trends, share insights, and learn from one another. To ensure a valuable experience for everyone, we ask that you adhere to the following guidelines: 🟢Be professional and respectful: Treat all members with respect. Maintain a professional tone in all comments and posts. Harassment, hateful speech, and discriminatory comments will not be tolerated. 🟢Keep it relevant: Ensure that your contributions are related to biopharma, pharma and food industries, market trends, or professional development within our sector. 🟢Focus on value: Share your expertise, case studies, or interesting articles that spark discussion. 🟢Engage in good faith: We encourage active, thoughtful discussion. Ask questions, share your opinions, and provide feedback on posts. 🟢Protect confidentiality: Do not share confidential, proprietary, or private information regarding Syntegon, our projects, clients or partners. 🟢No spamming: Posting the same comment or linking multiple times, or excessive posting is not allowed. We reserve the right to remove spam. 🟢Respect Intellectual Property: Please ensure that any content you share does not violate the copyright of others. We reserve the right to moderate, edit, report, or remove content that violates these rules.

The Krones Group, headquartered in Neutraubling, Germany, plans, develops, and manufactures machines and complete lines for the fields of process technology, bottling, canning and packaging, plus intralogistics and recycling. Krones’ success is based on a few crucial strategies: specialised knowledge of mechanical engineering and its customers’ sectoral needs, a technical lead in its chosen field, thanks to continuingly high expenditure on research and development, a manufacturing operation using state-of-the-art equipment to stringent standards of qualitative excellence, plus globalised 24/7 service support, all backed up by a highly qualified and enthusiastically motivated workforce. Imprint: https://www.krones.com/en/site-notice.php Data Protection: https://www.krones.com/en/data-protection.php